| Ytd | -52.30% | |
| 1y | -92.30% |
| Open | 3.09 | Prev Close | 3.09 | Low | 2.91 | High | 3.17 | Mkt Cap | 42.59M |
| Vol | 72.91K | Avg Vol | 40.26K | EPS | -1.39 | P/E | N/A | Forward P/E | N/A |
| Beta | -0.01 | Short Ratio | 1.12 | Inst. Own | 7.60% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-10 | 50-d Avg | 3.24 | 200-d Avg | 5.24 | 1yr Est | 0.00 |
QTI News
NOVATO, Calif.--(BUSINESS WIRE)---- $QTI #BreastCancer--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT
QT Imaging Holdings, Inc. (QTI) Q2 2026 Earnings Call Transcript
QT Imaging Holdings (NASDAQ:QTI) reported quarterly losses of $(0.19) per share which beat the analy
QT Imaging Holdings (NASDAQ:QTI) affirms FY2026 sales outlook from $39.000 million to $39.000 millio
QT Imaging Holdings (NASDAQ:QTI) reported quarterly losses of $(0.75) per share which missed the ana
NOVATO, Calif.--(BUSINESS WIRE)---- $QTI #BreastCancer--QT Imaging Holding, Inc. (Nasdaq: QTI) (“QT
NOVATO, Calif.--(BUSINESS WIRE)---- $QTI #BreastCancer--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT
NOVATO, Calif.--(BUSINESS WIRE)---- $QTI #BreastCancer--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT
NOVATO, Calif.--(BUSINESS WIRE)---- $QTI #BreastCancer--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT
NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (“QT Imaging” or the “Company”) (NASDAQ:
[url="]QT Imaging Holdings, Inc.[/url](Nasdaq: QTI) (âQT Imagingâ or the âCompanyâ), a medic
Regulatory approval enables commercialization of QT Imaging's technology in Israel and supports
NOVATO, Calif.--(BUSINESS WIRE)---- $QTI #BreastCancer--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT
The FDA inspection reviewed QT Imaging’s Quality Management System (QMS) and related processes that
NOVATO, Calif.--(BUSINESS WIRE)---- $QTI #BreastCancer--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT
[url="]QT Imaging Holdings, Inc. [/url](Nasdaq: QTI) (âQT Imagingâ or the âCompanyâ), a medi
NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Compa
Allows for Commercial Deployment of the Company's Radiation-Free Breast Imaging Technology Under
NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Compa
QT Imaging Holdings, Inc. (Nasdaq: QTI) (âQT Imagingâ or the âCompanyâ), a medical device co
QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company"), a medical de
NOVATO, Calif.--(BUSINESS WIRE)---- $QTI #BreastCancerAwareness--QT Imaging Holdings, Inc. (Nasdaq:
NOVATO, Calif.--(BUSINESS WIRE)---- $QTI #BreastCancerAwareness--QT Imaging Holdings, Inc. (“QT Imag
QT Imaging Holdings, Inc. (âQT Imagingâ or the âCompanyâ) (Nasdaq: QTI), a medical device co
QT Imaging Holdings, Inc. ("QT Imaging" or the "Company") (NASDAQ:QTI), a medical de
NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (“QT Imaging” or the “Company”) (Nasdaq:
QT Imaging Holdings, Inc. (QTI) Q1 2026 Earnings Call Transcript
QT Imaging Holdings, Inc. (Nasdaq: QTI) (âQT Imagingâ or the âCompanyâ), a medical device co
QT Imaging Holdings (NASDAQ:QTI) affirms FY2026 sales outlook from $39.000 million to $39.000 millio
QT Imaging Holdings (NASDAQ:QTI) reported quarterly losses of $(0.25) per share which missed the ana
QT IMAGING HOLDINGS, INC.Up to $100,000,000Common StockPreferred StockDebt SecuritiesWarrantsUnitsWe
QT Imaging Holdings (NASDAQ:QTI) reported quarterly losses of $(0.10) per share which beat the analy
Allows for Commercial Deployment of the Company's Radiation-Free Breast Imaging Technology Under
https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K253898
